Alex Zhavoronkov, CEO of Insilico Medicine, discusses how AI speeds up drug discovery by 4x, reducing preclinical time to 12-18 months. The company targets aging at its core and aims to repurpose drugs for longevity. He believes breakthroughs in extending lifespan by 10+ years are possible within 10-15 years.
Yields
NDX
RUT
Oil
Metals
USD
Insilico Medicine 2.5
Health Care
Alex Zhavoronkov 6.0
6/12/2026 3:31:49 PM

SignalTube

markets at a glance